Matthew <span>B.</span> Schabath, PhD

Matthew B. Schabath, PhD

Academic Rank: Associate Member


Lung cancer is the leading cause of cancer death for both men and women in the United States.  The low patient survival and high fatality rate of this disease demonstrate the urgent need to improve lung cancer screening for early diagnosis and advance precision-based medicine to improve clinical outcomes for lung cancer patients.


    • Cancer Epidemiology
    • Thoracic Oncology
    • Cancer Epidemiology Program
    • Lung Cancer Center of Excellence
    • Cancer Chemoprevention Research Interest Group
    • Center for Immunization and Infection Research in

Education & Training

    • University of Texas School of Public Health, MS - Epidemiology
    • University of Texas School of Public Health, PhD - Epidemiology
    • University of Texas MD Anderson Cancer Center, Postdoctoral Fellow - Cancer Epidemiology & Prevention

Dr. Matthew Schabath is an Assistant Member in the Department of Cancer Epidemiology. He received his Ph.D. in Epidemiology from the University of Texas in 2003 and has over 16 years of experience studying tobacco-related diseases including lung cancer, bladder cancer, COPD, and heart disease. Dr. Schabath has over 65 peer-reviewed publications, of which over 60% are related to lung cancer and pulmonary disease. Dr. Schabath’s earliest work focused on etiology and susceptibility with a particular focus on the interplay of germline genetics and exposures on lung cancer risk. Dr. Schabath was a co-author on one of the earliest Lung Cancer Risk Models (Spitz et al., JNCI) and on one of the first GWAS of pulmonary function (Hancock et al., Nat Genetics). His work was also among the first to reveal novel associations for lung cancer risk including: high intake of phytoestrogens associated with reduced risk of lung cancer (Schabath et al., JAMA), hormone replacement therapy associated with reduced risk of lung cancer risk in women (Schabath et al., Clin Cancer Res), and emphysema, hay fever, and functional genetic variants have opposing effects on lung cancer risk (Schabath et al., AJEpi). Dr. Schabath’s current research portfolio as it relates to lung cancer has expanded to investigating: i) the interplay of quantitative imaging and genomics on lung cancer patient outcomes, ii) diagnostic and predictive quantitative imaging models in lung cancer screening, iii) germline and somatic mutations on lung cancer treatment response and patient outcomes, and iv) predictive and prognostic gene expression signatures in lung cancer treatment response. Dr. Schabath’s research portfolio has also expanded to include infectious disease research and health disparities research including sexual and gender minority (SGM) populations and racial/ethnic minority groups. In addition to his primary research interests, Dr. Schabath is active within the scientific community as a regular reviewer for numerous journals, a member of the NCCN Lung Cancer Screening guidelines committee, and is on the editorial boards of Molecular Carcinogenesis, Cancer Research, BMC Cancer, PLOS ONE, and Cancer Medicine.


  • Li Y, Xiao X, Han Y, Gorlova O, Qian D, Leighl N, Johansen JS, Barnett M, Chen C, Goodman G, Cox A, Taylor F, Woll P, Wichmann HE, Manz J, Muley T, Risch A, Rosenberger A, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Zienolddiny S, Duell EJ, Butler LM, Houlston R, Artigas MS, Grankvist K, Johansson M, Shepherd FA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Liu G, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Bertazzi PA, Pesatori AC, Christiani DC, Caporaso N, Johansson M, McKay JD, Brennan P, Hung RJ, Amos CI. Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis. 2018 Mar;39(3):336-346. Pubmedid: 29059373.
  • Li Q, Balagurunathan Y, Liu Y, Qi J, Schabath MB, Ye Z, Gillies RJ. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial. Clin Lung Cancer. 2018 Mar;19(2):148-156.e3. Pubmedid: 29137847. Pmcid: PMC5825260.
  • Liu Y, Kim J, Balagurunathan Y, Hawkins S, Stringfield O, Schabath MB, Li Q, Qu F, Liu S, Garcia AL, Ye Z, Gillies RJ. Prediction of pathological nodal involvement by CT-based Radiomic features of the primary tumor in patients with clinically node-negative peripheral lung adenocarcinomas. Med Phys. 2018 Jun;45(6):2518-2526. Pubmedid: 29624702.
  • Rosenberger A, Hung RJ, Christiani DC, Caporaso NE, Liu G, Bojesen SE, Le Marchand L, Haiman CA, Albanes D, Aldrich MC, Tardon A, Fernández-Tardón G, Rennert G, Field JK, Kiemeney B, Lazarus P, Haugen A, Zienolddiny S, Lam S, Schabath MB, Andrew AS, Brunnsstöm H, Goodman GE, Doherty JA, Chen C, Teare MD, Wichmann HE, Manz J, Risch A, Muley TR, Johansson M, Brennan P, Landi MT, Amos CI, Pesch B, Johnen G, Brüning T, Bickeböller H, Gomolka M. Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health. 2018 Jul. Pubmedid: 29971594.
  • Liu Y, Wang H, Li Q, McGettigan MJ, Balagurunathan Y, Garcia AL, Thompson ZJ, Heine JJ, Ye Z, Gillies RJ, Schabath MB. Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study. Radiology. 2018 Jan;286(1):298-306. Pubmedid: 28837413. Pmcid: PMC5738292.
  • Paul R, Hawkins SH, Schabath MB, Gillies RJ, Hall LO, Goldgof DB. Predicting malignant nodules by fusing deep features with classical radiomics features. J Med Imaging (Bellingham). 2018 Jan;5(1):011021. Pubmedid: 29594181. Pmcid: PMC5862127.
  • Rice D, Schabath MB. The Future of LGBT Cancer Care: Practice and Research Implications. Semin Oncol Nurs. 2018 Feb;34(1):99-115. Pubmedid: 29329960.
  • Schabath MB. Risk models to select high risk candidates for lung cancer screening. Ann Transl Med. 2018 Feb;6(3):65. Pubmedid: 29611557. Pmcid: PMC5879506.
  • Quinn G, Pentz RD, Muñoz-Antonia T, Boyle TA, Schabath MB, Pratt C, Shaffer A, Duarte L, Bowman-Curci M, Antonia S, Chiappori A, Creelan B, Gray JE, Williams C, Haura E. Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program. Patient Educ Couns. 2018 Apr;101(4):703-710. Pubmedid: 29195718. Pmcid: PMC5878993.
  • Wheldon CW, Schabath MB, Hudson J, Bowman Curci M, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Quinn GP. Culturally Competent Care for Sexual and Gender Minority Patients at National Cancer Institute-Designated Comprehensive Cancer Centers. LGBT Health. 2018 Apr;5(3):203-211. Pubmedid: 29641317. Pmcid: PMC5905865.
  • Wood DE, Kazerooni EA, Baum SL, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Makani SS, Massion PP, Mazzone P, Merritt RE, Meyers BF, Midthun DE, Pipavath S, Pratt C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Schiebler ML, Tong BC, Travis WD, Wei B, Yang SC, Gregory KM, Hughes M. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Ne. 2018 Apr;16(4):412-441. Pubmedid: 29632061.
  • Li Q, Kim J, Balagurunathan Y, Qi J, Liu Y, Latifi K, Moros EG, Schabath MB, Ye Z, Gillies RJ, Dilling TJ. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy. Radiat Oncol. 2017 Sep;12(1):158. Pubmedid: 28946909. Pmcid: PMC5613447.
  • Wang T, Moon JY, Wu Y, Amos CI, Hung RJ, Tardon A, Andrew A, Chen C, Christiani DC, Albanes D, Heijden EHFMV, Duell E, Rennert G, Goodman G, Liu G, Mckay JD, Yuan JM, Field JK, Manjer J, Grankvist K, Kiemeney LA, Marchand LL, Teare MD, Schabath MB, Johansson M, Aldrich MC, Davies M, Johansson M, Tsao MS, Caporaso N, Lazarus P, Lam S, Bojesen SE, Arnold S, Wu X, Zong X, Hong YC, Ho GYF. Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium. PLoS One. 2017 Sep;12(9):e0185660. Pubmedid: 28957450. Pmcid: PMC5619832.
  • Tamargo CL, Quinn GP, Sanchez JA, Schabath MB. Cancer and the LGBTQ Population: Quantitative and Qualitative Results from an Oncology Providers' Survey on Knowledge, Attitudes, and Practice Behaviors. J Clin Med. 2017 Oct;6(10). Pubmedid: 28991160. Pmcid: PMC5664008.
  • Tunali I, Stringfield O, Guvenis A, Wang H, Liu Y, Balagurunathan Y, Lambin P, Gillies RJ, Schabath MB. Radial gradient and radial deviation radiomic features from pre-surgical CT scans are associated with survival among lung adenocarcinoma patients. Oncotarget. 2017 Nov;8(56):96013-96026. Pubmedid: 29221183. Pmcid: PMC5707077.
  • Hudson J, Schabath MB, Sanchez J, Sutton S, Simmons VN, Vadaparampil ST, Kanetsky PA, Quinn GP. Sexual and Gender Minority Issues Across NCCN Guidelines: Results From a National Survey. J Natl Compr Canc Ne. 2017 Nov;15(11):1379-1382. Pubmedid: 29118229. Pmcid: PMC5705047.
  • Liu Y, Balagurunathan Y, Atwater T, Antic S, Li Q, Walker RC, Smith G, Massion PP, Schabath MB, Gillies RJ. Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules. Clin Cancer Res. 2017 Mar;23(6):1442-1449. Pubmedid: 27663588. Pmcid: PMC5527551.
  • Shafiq-Ul-Hassan M, Zhang GG, Latifi K, Ullah G, Hunt DC, Balagurunathan Y, Abdalah MA, Schabath MB, Goldgof DG, Mackin D, Court LE, Gillies RJ, Moros EG. Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels. Med Phys. 2017 Mar;44(3):1050-1062. Pubmedid: 28112418. Pmcid: PMC5462462.
  • Carreras-Torres R, Johansson M, Haycock PC, Wade KH, Relton CL, Martin RM, Davey Smith G, Albanes D, Aldrich MC, Andrew A, Arnold SM, Bickeböller H, Bojesen SE, Brunnström H, Manjer J, Brüske I, Caporaso NE, Chen C, Christiani DC, Christian WJ, Doherty JA, Duell EJ, Field JK, Davies MPA, Marcus MW, Goodman GE, Grankvist K, Haugen A, Hong YC, Kiemeney LA, van der Heijden EHFM, Kraft P, Johansson MB, Lam S, Landi MT, Lazarus P, Le Marchand L, Liu G, Melander O, Park SL, Rennert G, Risch A, Haura EB, Scelo G, Zaridze D, Mukeriya A, Savić M, Lissowska J, Swiatkowska B, Janout V, Holcatova I, Mates D, Schabath MB, Shen H, Tardon A, Teare MD, Woll P, Tsao MS, Wu X, Yuan JM, Hung RJ, Amos CI, McKay J, Brennan P. Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLoS One. 2017 Jun;12(6):e0177875. Pubmedid: 28594918. Pmcid: PMC5464539.
  • McKay JD, Hung RJ, Han Y, Zong X, Carreras-Torres R, Christiani DC, Caporaso NE, Johansson M, Xiao X, Li Y, Byun J, Dunning A, Pooley KA, Qian DC, Ji X, Liu G, Timofeeva MN, Bojesen SE, Wu X, Le Marchand L, Albanes D, Bickeböller H, Aldrich MC, Bush WS, Tardon A, Rennert G, Teare MD, Field JK, Kiemeney LA, Lazarus P, Haugen A, Lam S, Schabath MB, Andrew AS, Shen H, Hong YC, Yuan JM, Bertazzi PA, Pesatori AC, Ye Y, Diao N, Su L, Zhang R, Brhane Y, Leighl N, Johansen JS, Mellemgaard A, Saliba W, Haiman CA, Wilkens LR, Fernandez-Somoano A, Fernandez-Tardon G, van der Heijden HFM, Kim JH, Dai J, Hu Z, Davies MPA, Marcus MW, Brunnström H, Manjer J, Melander O, Muller DC, Overvad K, Trichopoulou A, Tumino R, Doherty JA, Barnett MP, Chen C, Goodman GE, Cox A, Taylor F, Woll P, Brüske I, Wichmann HE, Manz J, Muley TR, Risch A, Rosenberger A, Grankvist K, Johansson M, Shepherd FA, Tsao MS, Arnold SM, Haura EB, Bolca C, Holcatova I, Janout V, Kontic M, Lissowska J, Mukeria A, Ognjanovic S, Orlowski TM, Scelo G, Swiatkowska B, Zaridze D, Bakke P, Skaug V, Zienolddiny S, Duell EJ, Butler LM, Koh WP, Gao YT, Houlston RS, McLaughlin J, Stevens VL, Joubert P, Lamontagne M, Nickle DC, Obeidat M, Timens W, Zhu B, Song L, Kachuri L, Artigas MS, Tobin MD, Wain LV, Rafnar T, Thorgeirsson TE, Reginsson GW, Stefansson K, Hancock DB, Bierut LJ, Spitz MR, Gaddis NC, Lutz SM, Gu F, Johnson EO, Kamal A, Pikielny C, Zhu D, Lindströem S, Jiang X, Tyndale RF, Chenevix-Trench G, Beesley J, Bossé Y, C ...
  • Martin RC, Burgin WS, Schabath MB, Kirby B, Chae SH, Fradley MG, Rose DZ, Labovitz AJ. Gender-Specific Differences for Risk of Disability and Death in Atrial Fibrillation-Related Stroke. Am J Cardiol. 2017 Jan;119(2):256-261. Pubmedid: 27846983.
  • Cohen AS, Khalil FK, Welsh EA, Schabath MB, Enkemann SA, Davis A, Zhou JM, Boulware DC, Kim J, Haura EB, Morse DL. Cell-surface marker discovery for lung cancer. Oncotarget. 2017 Dec;8(69):113373-113402. Pubmedid: 29371917. Pmcid: PMC5768334.
  • Lohavanichbutr P, Sakoda LC, Amos CI, Arnold SM, Christiani DC, Davies MPA, Field JK, Haura EB, Hung RJ, Kohno T, Landi MT, Liu G, Liu Y, Marcus MW, O'Kane GM, Schabath MB, Shiraishi K, Slone SA, Tardon A, Yang P, Yoshida K, Zhang R, Zong X, Goodman GG, Weiss NS, Chen C. Common Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. Clin Cancer Res. 2017 Dec;23(24):7550-7557. Pubmedid: 28974547. Pmcid: PMC5732876.
  • Gimbrone NT, Sarcar B, Gordian ER, Rivera JI, Lopez C, Yoder SJ, Teer JK, Welsh EA, Chiaporri AA, Schabath MB, Reuther GW, Dutil J, Garcia M, Ventosilla-Villanueva R, Vera-Valdivia L, Yabar-Berrocal A, Motta-Guerrero R, Santiago-Cardona PG, Muñoz-Antonia T, Cress WD. Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients. J Thorac Oncol. 2017 Dec;12(12):1851-1856. Pubmedid: 28911955. Pmcid: PMC5701827.
  • Schabath MB, Curci MB, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Wheldon C, Quinn GP. Ask and Tell: The Importance of the Collection of Sexual Orientation and Gender Identity Data to Improve the Quality of Cancer Care for Sexual and Gender Minorities. J Oncol Pract. 2017 Aug;13(8):542-546. Pubmedid: 28719237.
  • Li Q, Kim J, Balagurunathan Y, Liu Y, Latifi K, Stringfield O, Garcia A, Moros EG, Dilling TJ, Schabath MB, Ye Z, Gillies RJ. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy. Med Phys. 2017 Aug;44(8):4341-4349. Pubmedid: 28464316. Pmcid: PMC5553698.
  • Simmons VN, Gray JE, Schabath MB, Wilson LE, Quinn GP. High-risk community and primary care providers knowledge about and barriers to low-dose computed topography lung cancer screening. Lung Cancer. 2017 Apr;106:42-49. Pubmedid: 28285693.
  • Shetty G, Sanchez JA, Lancaster JM, Wilson LE, Quinn GP, Schabath MB. Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT health. Patient Educ Couns. 2016 Oct;99(10):1676-1684. Pubmedid: 27161166. Pmcid: PMC5527558.
  • Sharma P, Zargar-Shoshtari K, Pettaway CA, Schabath MB, Giuliano AR, Spiess PE. Disparities in Penile Cancer. Cancer Control. 2016 Oct;23(4):409-414. Pubmedid: 27842330.
  • Schabath MB, Cress D, Munoz-Antonia T. Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer. Cancer Control. 2016 Oct;23(4):338-346. Pubmedid: 27842323. Pmcid: PMC5340153.
  • Wang H, Schabath MB, Liu Y, Han Y, Li Q, Gillies RJ, Ye Z. Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations. Eur J Radiol. 2016 Nov;85(11):1934-1940. Pubmedid: 27776643. Pmcid: PMC5123695.
  • Schabath MB, Welsh EA, Fulp WJ, Chen L, Teer JK, Thompson ZJ, Engel BE, Xie M, Berglund AE, Creelan BC, Antonia SJ, Gray JE, Eschrich SA, Chen DT, Cress WD, Haura EB, Beg AA. Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. Oncogene. 2016 Jun;35(24):3209-3216. Pubmedid: 26477306. Pmcid: PMC4837098.
  • Chen L, Engel BE, Welsh EA, Yoder SJ, Brantley SG, Chen DT, Beg AA, Cao C, Kaye FJ, Haura EB, Schabath MB, Cress WD. A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma. J Thorac Oncol. 2016 Jun;11(6):838-849. Pubmedid: 26917230. Pmcid: PMC4877210.
  • Wang H, Schabath MB, Liu Y, Stringfield O, Balagurunathan Y, Heine JJ, Eschrich SA, Ye Z, Gillies RJ. Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value. Clin Lung Cancer. 2016 Jul;17(4):271-278. Pubmedid: 26712103. Pmcid: PMC4887405.
  • Chen L, Kurtyka CA, Welsh EA, Rivera JI, Engel BE, Muñoz-Antonia T, Yoder SJ, Eschrich SA, Creelan BC, Chiappori AA, Gray JE, Ramirez JL, Rosell R, Schabath MB, Haura EB, Chen DT, Cress WD. Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma. Oncotarget. 2016 Dec;7(50):82254-82265. Pubmedid: 27756884. Pmcid: PMC5347689.
  • Paul R, Hawkins SH, Balagurunathan Y, Schabath MB, Gillies RJ, Hall LO, Goldgof DB. Deep Feature Transfer Learning in Combination with Traditional Features Predicts Survival Among Patients with Lung Adenocarcinoma. Tomography. 2016 Dec;2(4):388-395. Pubmedid: 28066809. Pmcid: PMC5218828.
  • Schabath MB, Massion PP, Thompson ZJ, Eschrich SA, Balagurunathan Y, Goldof D, Aberle DR, Gillies RJ. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial. PLoS One. 2016 Aug;11(8):e0159880. Pubmedid: 27509046. Pmcid: PMC4980050.
  • Hawkins S, Wang H, Liu Y, Garcia A, Stringfield O, Krewer H, Li Q, Cherezov D, Gatenby RA, Balagurunathan Y, Goldgof D, Schabath MB, Hall L, Gillies RJ. Predicting Malignant Nodules from Screening CT Scans. J Thorac Oncol. 2016 12;11(12):2120-2128. Pubmedid: 27422797. Pmcid: PMC5545995.
  • Chen Z, Li JL, Lin S, Cao C, Gimbrone NT, Yang R, Fu DA, Carper MB, Haura EB, Schabath MB, Lu J, Amelio AL, Cress WD, Kaye FJ, Wu L. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. J Clin Invest. 2016 06;126(6):2267-2279. Pubmedid: 27140397. Pmcid: PMC4887185.
  • Schabath MB, Gillies RJ. Noninvasive Quantitative Imaging-based Biomarkers and Lung Cancer Screening. Am J Respir Crit Care Med. 2015 Sep;192(6):654-656. Pubmedid: 26371810. Pmcid: PMC5447294.
  • Baldelli E, Bellezza G, Haura EB, Crinó L, Cress WD, Deng J, Ludovini V, Sidoni A, Schabath MB, Puma F, Vannucci J, Siggillino A, Liotta LA, Petricoin EF, Pierobon M. Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors. Oncotarget. 2015 Oct;6(32):32368-32379. Pubmedid: 26468985. Pmcid: PMC4741699.
  • Baldelli E, Haura EB, Crinò L, Cress WD, Ludovini V, Schabath MB, Liotta LA, Petricoin EF, Pierobon M. Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine. Proteom Clin Appl. 2015 Oct;9(9-10):928-937. Pubmedid: 25676683. Pmcid: PMC4547918.
  • Wang H, Schabath MB, Liu Y, Berglund AE, Bloom GC, Kim J, Stringfield O, Eikman EA, Klippenstein DL, Heine JJ, Eschrich SA, Ye Z, Gillies RJ. Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival. Clin Lung Cancer. 2015 Nov;16(6):e141-e163. Pubmedid: 26077095. Pmcid: PMC4609593.
  • Schabath MB, DiGiovanni J. Introduction to special issue: Recent advances in mechanisms, prevention and treatment of lung cancer. Mol Carcinogen. 2015 Jun;54 Suppl 1:vi. Pubmedid: 26089261.
  • Woods NT, Monteiro AN, Thompson ZJ, Amankwah EK, Naas N, Haura EB, Beg AA, Schabath MB. Interleukin polymorphisms associated with overall survival, disease-free survival, and recurrence in non-small cell lung cancer patients. Mol Carcinogen. 2015 Jun;54 Suppl 1:E172-E184. Pubmedid: 25597281. Pmcid: PMC4475444.
  • Quinn GP, Sutton SK, Winfield B, Breen S, Canales J, Shetty G, Sehovic I, Green BL, Schabath MB. Lesbian, Gay, Bisexual, Transgender, Queer/Questioning (LGBTQ) Perceptions and Health Care Experiences. J Gay Lesbian Soc Serv. 2015 Jul;27(2):246-261.
  • Wood DE, Kazerooni E, Baum SL, Dransfield MT, Eapen GA, Ettinger DS, Hou L, Jackman DM, Klippenstein D, Kumar R, Lackner RP, Leard LE, Leung AN, Makani SS, Massion PP, Meyers BF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Sachs PB, Schabath MB, Sequist LV, Tong BC, Travis WD, Yang SC, Gregory KM, Hughes M. Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. J Natl Compr Canc Ne. 2015 Jan;13(1):23-34. Pubmedid: 25583767.
  • Smith MA, Hall R, Fisher K, Haake SM, Khalil F, Schabath MB, Vuaroqueaux V, Fiebig HH, Altiok S, Chen YA, Haura EB. Annotation of human cancers with EGFR signaling-associated protein complexes using proximity ligation assays. Sci Signal. 2015 Jan;8(359):ra4. Pubmedid: 25587191. Pmcid: PMC4440040.
  • Schabath MB, Thompson ZJ, Egan KM, Torres BN, Nguyen A, Papenfuss MR, Abrahamsen ME, Giuliano AR. Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men in the HPV in Men (HIM) study. Sex Transm Infect. 2015 Feb;91(1):61-67. Pubmedid: 25278617. Pmcid: PMC4342055.
  • Hampras SS, Rollison DE, Tommasino M, Gheit T, Schabath MB, Messina JL, Fenske NA, Cherpelis BS, Sondak VK, Iannacone MR, Schmitt M, Pawlita M. Genetic variations in the epidermodysplasia verruciformis (EVER/TMC) genes, cutaneous human papillomavirus infection and squamous cell carcinoma of the skin. Br J Dermatol. 2015 Dec;173(6):1532-1535. Pubmedid: 26126409. Pmcid: PMC4695259.
  • Quinn GP, Sanchez JA, Sutton SK, Vadaparampil ST, Nguyen GT, Green BL, Kanetsky PA, Schabath MB. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA-Cancer J Clin. 2015 Dec;65(5):384-400. Pubmedid: 26186412. Pmcid: PMC4609168.
  • Ingles DJ, Lin HY, Fulp WJ, Sudenga SL, Lu B, Schabath MB, Papenfuss MR, Abrahamsen ME, Salmeron J, Villa LL, Ponce EL, Giuliano AR. An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study. Papillomavirus Res. 2015 Dec;1:126-135. Pubmedid: 27547836. Pmcid: PMC4986989.
  • Quinn GP, Schabath MB, Sanchez JA, Sutton SK, Green BL. The importance of disclosure: lesbian, gay, bisexual, transgender/transsexual, queer/questioning, and intersex individuals and the cancer continuum. Cancer. 2015 Apr;121(8):1160-1163. Pubmedid: 25521303. Pmcid: PMC4505934.
  • Grove O, Berglund AE, Schabath MB, Aerts HJ, Dekker A, Wang H, Velazquez ER, Lambin P, Gu Y, Balagurunathan Y, Eikman E, Gatenby RA, Eschrich S, Gillies RJ. Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. PLoS One. 2015;10(3):e0118261. Pubmedid: 25739030. Pmcid: PMC4349806.
  • Schabath MB, Nguyen A, Wilson P, Sommerer KR, Thompson ZJ, Chiappori AA. Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients. Lung Cancer. 2014 Oct;86(1):14-21. Pubmedid: 25115410. Pmcid: PMC4171454.
  • Schabath MB, Villa LL, Lin HY, Fulp WJ, Lazcano-Ponce E, Salmerón J, Abrahamsen ME, Papenfuss MR, Quiterio M, Giuliano AR. A prospective analysis of smoking and human papillomavirus infection among men in the HPV in Men Study. Int J Cancer. 2014 May;134(10):2448-2457. Pubmedid: 24222514. Pmcid: PMC3949156.
  • Donatelli SS, Zhou JM, Gilvary DL, Eksioglu EA, Chen X, Cress WD, Haura EB, Schabath MB, Coppola D, Wei S, Djeu JY. TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells. Proc Natl Acad Sci U S A. 2014 Mar;111(11):4203-4208. Pubmedid: 24586048. Pmcid: PMC3964044.
  • Scholfield M, Schabath MB, Guglin M. Longitudinal trends, hemodynamic profiles, and prognostic value of abnormal liver function tests in patients with acute decompensated heart failure: an analysis of the ESCAPE trial. J Card Fail. 2014 Jul;20(7):476-484. Pubmedid: 24845963.
  • Schabath MB, Thompson ZJ, Gray JE. Temporal trends in demographics and overall survival of non-small-cell lung cancer patients at Moffitt Cancer Center from 1986 to 2008. Cancer Control. 2014 Jan;21(1):51-56. Pubmedid: 24357741. Pmcid: PMC4341967.
  • Schabath MB, McIntyre J, Pratt C, Gonzalez LE, Munoz-Antonia T, Haura EB, Quinn GP. Healthcare providers' knowledge and attitudes about rapid tissue donation (RTD): phase one of establishing a rapid tissue donation programme in thoracic oncology. J Med Ethics. 2014 Feb;40(2):139-142. Pubmedid: 23557908. Pmcid: PMC3924895.
  • McHugh MK, Schabath MB, Ho CH, Liu M, D'Amelio AM, Greisinger AJ, Delclos GL, Spitz MR, Etzel CJ. Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans. J Immigr Minor Health. 2013 Oct;15(5):910-917. Pubmedid: 22847640. Pmcid: PMC3919532.
  • Schabath MB, Villa LL, Lin HY, Fulp WJ, Akogbe GO, Abrahamsen ME, Papenfuss MR, Lazcano-Ponce E, Salermon J, Quiterio M, Giuliano AR. Racial differences in the incidence and clearance of human papilloma virus (HPV): the HPV in men (HIM) study. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1762-1770. Pubmedid: 23872745. Pmcid: PMC3795913.
  • Schabath MB, Giuliano AR, Thompson ZJ, Amankwah EK, Gray J, Fenstermacher DA, Jonathan KA, Beg AA, Haura EB. TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. Carcinogenesis. 2013 Nov;34(11):2525-2530. Pubmedid: 23839018. Pmcid: PMC3810840.
  • Quinn GP, Murphy D, Pratt C, Muñoz-Antonia T, Guerra L, Schabath MB, Leon ME, Haura E. Altruism in terminal cancer patients and rapid tissue donation program: does the theory apply?. Med Health Care Phil. 2013 Nov;16(4):857-864. Pubmedid: 23539332. Pmcid: PMC3735793.
  • Bloom GC, Eschrich S, Hang G, Schabath MB, Bhansali N, Hoerter AM, Morgan S, Fenstermacher DA. Development and application of a novel metric to assess effectiveness of biomedical data. BMJ Open. 2013 Aug;3(8):e003220. Pubmedid: 23975264. Pmcid: PMC3753524.
  • Kumar V, Gu Y, Basu S, Berglund A, Eschrich SA, Schabath MB, Forster K, Aerts HJ, Dekker A, Fenstermacher D, Goldgof DB, Hall LO, Lambin P, Balagurunathan Y, Gatenby RA, Gillies RJ. Radiomics: the process and the challenges. Magn Reson Imaging. 2012 Nov;30(9):1234-1248. Pubmedid: 22898692. Pmcid: PMC3563280.
  • Schabath MB, Villa LL, Lazcano-Ponce E, Salmerón J, Quiterio M, Giuliano AR. Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study. Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):102-110. Pubmedid: 22016473. Pmcid: PMC3253903.
  • Wood DE, Eapen GA, Ettinger DS, Hou L, Jackman D, Kazerooni E, Klippenstein D, Lackner RP, Leard L, Leung AN, Massion PP, Meyers BF, Munden RF, Otterson GA, Peairs K, Pipavath S, Pratt-Pozo C, Reddy C, Reid ME, Rotter AJ, Schabath MB, Sequist LV, Tong BC, Travis WD, Unger M, Yang SC. Lung cancer screening. J Natl Compr Canc Netw. 2012 Feb;10(2):240-265. Pubmedid: 22308518.
  • Akogbe GO, Ajidahun A, Sirak B, Anic GM, Papenfuss MR, Fulp WJ, Lin HY, Abrahamsen M, Villa LL, Lazcano-Ponce E, Quiterio M, Smith D, Schabath MB, Salmeron J, Giuliano AR. Race and prevalence of human papillomavirus infection among men residing in Brazil, Mexico and the United States. Int J Cancer. 2012 Aug;131(3):E282-E291. Pubmedid: 22161806. Pmcid: PMC3458422.
  • Hesselbacher SE, Ross R, Schabath MB, Smith EO, Perusich S, Barrow N, Smithwick P, Mammen MJ, Coxson H, Krowchuk N, Corry DB, Kheradmand F. Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers. Int J Environ Res Public Health. 2011 May;8(5):1324-1340. Pubmedid: 21655122. Pmcid: PMC3108112.
  • Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH, Barr RG, Schabath MB, Couper DJ, Brusselle GG, Psaty BM, van Duijn CM, Rotter JI, Uitterlinden AG, Hofman A, Punjabi NM, Rivadeneira F, Morrison AC, Enright PL, North KE, Heckbert SR, Lumley T, Stricker BH, O'Connor GT, London SJ. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genetics. 2010 Jan;42(1):45-52. Pubmedid: 20010835. Pmcid: PMC2832852.
  • Barahmani N, Schabath MB, Duvic M. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009 Oct;61(4):581-591. Pubmedid: 19608295.
  • Chamberlain AM, Schabath MB, Folsom AR. Associations of chronic obstructive pulmonary disease with all-cause mortality in Blacks and Whites: the atherosclerosis risk in communities (ARIC) study. Ethnic Dis. 2009 Oct;19(3):308-314. Pubmedid: 19769014. Pmcid: PMC2826210.
  • Nettleton JA, Follis JL, Schabath MB. Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2009 Jun;169(12):1445-1453. Pubmedid: 19372215. Pmcid: PMC2727200.
  • Spitz M, Hong W, Amos C, Wu X, Schabath M, Dong Q, Shete S, Etzel C. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May;99(9):715-726. Pubmedid: 17470739.
  • Wilkinson A, Schabath M, Prokhorov A, Spitz M. Age-related differences in factors associated with smoking initiation. Cancer Causes Control. 2007 Aug;18(6):635-644. Pubmedid: 17473909.
  • El-Zein R, Schabath M, Etzel C, Lopez M, Franklin J, Spitz M. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res. 2006 Jun;66(12):6449-6456. Pubmedid: 16778224.
  • Schabath M, Wu X, Wei Q, Li G, Gu J, Spitz M. Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):158-161. Pubmedid: 16434604.
  • Kader A, Shao L, Dinney C, Schabath M, Wang Y, Liu J, Gu J, Grossman H, WuX. Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res. 2006 Dec;66(24):11644-11648. Pubmedid: 17178858.
  • Gorlova O, Zhang Y, Schabath M, Lei L, Zhang Q, Amos C, Spitz M. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006 Apr;118(7):1798-1804. Pubmedid: 16217766.
  • Schabath M, Hernandez L, Wu X, Pillow P, Spitz M. Dietary phytoestrogens and lung cancer risk. Jama. 2005 Sep;294(12):1493-1504. Pubmedid: 16189362.
  • Schabath M, Delclos G, Martynowicz M, Greisinger A, Lu C, Wu X, Spitz M. Opposing effects of emphysema, hay fever, and select genetic variants on lung cancer risk. Am J Epidemiol. 2005 Mar;161(5):412-422. Pubmedid: 15718477.
  • Schabath MB, Delclos GL, Grossman HB, Wang Y, Lerner SP, Chamberlain RM, Spitz MR, Wu X. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):878-884. Pubmedid: 15824159.
  • Schabath M, Spitz M, Lerner S, Pillow P, Hernandez L, Delclos G, Grossman H, Wu X. Case-control analysis of dietary folate and risk of bladder cancer. Nutr Cancer. 2005;53(2):144-151. Pubmedid: 16573375.
  • Lin J, Spitz M, Wang Y, Schabath M, Gorlov I, Hernandez L, Pillow P, Grossman H, Wu X. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis. 2004 Sep;25(9):1639-1647. Pubmedid: 15117811.
  • Zhu Y, Spitz MR, Amos CI, Lin J, Schabath MB, Wu X. An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology. Cancer Res. 2004 Mar;64(6):2251-2257. Pubmedid: 15026370.
  • Schabath M, Wu X, Vassilopoulou-Sellin R, Vaporciyan A, Spitz M. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004 Jan;10(1 Pt 1):113-123. Pubmedid: 14734459.
  • Schabath M, Grossman H, Delclos G, Hernandez L, Day R, Davis B, LernerSP, Spitz M, Wu X. Dietary carotenoids and genetic instability modify bladder cancer risk. J Nutr. 2004 Dec;134(12):3362-3369. Pubmedid: 15570038.
  • Zheng L, Wang Y, Schabath MB, Grossman HB, Wu X. Sulfotransferase 1A1 (SULT1A1) polymorphism and bladder cancer risk: a case-control study. Cancer Lett. 2003 Dec;202(1):61-69. Pubmedid: 14643027.
  • Wang Y, Spitz M, Schabath M, Ali-Osman F, Mata H, Wu X. Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. Lung Cancer. 2003 Apr;40(1):25-32. Pubmedid: 12660004.
  • Schabath M, Spitz M, Grossman H, Zhang K, Dinney C, Zheng P, Wu X. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst. 2003 Apr;95(7):540-547. Pubmedid: 12671022.
  • Wu X, Schabath MB, Spitz MR. Myeloperoxidase promoter region polymorphism and lung cancer risk. Methods Mol Med. 2003;75:121-133. Pubmedid: 12407737.
  • Schabath M, Spitz M, Delclos G, Gunn G, Whitehead L, Wu X. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med. 2002 Jul;42(1):29-37. Pubmedid: 12111688.
  • Schabath MB, Spitz MR, Hong WK, Delclos GL, Reynolds WF, Gunn GB, Whitehead LW, Wu X. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer. 2002 Jul;37(1):35-40. Pubmedid: 12057865.
  • Zhang H, Spitz M, Tomlinson G, Schabath M, Minna J, Wu X. Modification of lung cancer susceptibility by green tea extract as measured by the comet assay. Cancer Detect Prev. 2002;26(6):411-418. Pubmedid: 12507225.
  • Schabath M, Spitz M, Zhang X, Delclos G, Wu X. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis. 2000 Jun;21(6):1163-1166. Pubmedid: 10837005.